Sale!

Hains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test Cost

Original price was: 470 د.إ.Current price is: 420 د.إ.

-11%

The “Hains Mycobacterium Tuberculosis First Line Drug Resistance Profile Test” is a diagnostic assay performed by DNA Labs UAE, designed to identify resistance to the first-line drugs used in the treatment of tuberculosis (TB). This test is particularly crucial for tailoring the most effective treatment plans for patients, by detecting any resistance to drugs such as isoniazid, rifampicin, ethambutol, and pyrazinamide, which are commonly used in the management of TB. The resistance profile is determined through molecular diagnostic techniques, which offer a rapid and accurate means of identifying mutations in the Mycobacterium tuberculosis DNA that are known to confer resistance to these medications. By doing so, the test plays a vital role in combating the spread of drug-resistant TB strains, ensuring patients receive the most appropriate therapy from the outset, and thereby improving treatment outcomes. The test is priced at 420 AED, reflecting its value in providing crucial information for effective TB management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test

Test Cost: AED 420.0

Symptoms, Diagnosis, and Test Details

The HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test is a molecular diagnostic test offered by DNA Labs UAE. This test is used to detect drug resistance mutations in the genes associated with resistance to first-line anti-tuberculosis drugs.

The test specifically targets the genes rpoB, katG, and inhA, which are associated with resistance to rifampicin and isoniazid, two commonly used first-line drugs for tuberculosis treatment.

The HAINS test utilizes polymerase chain reaction (PCR) technology to amplify and detect specific genetic regions of interest in the Mycobacterium tuberculosis genome. The amplified DNA is then hybridized with specific probes to identify drug resistance mutations.

The results of the test provide valuable information on the presence or absence of drug resistance mutations in the targeted genes. This information helps guide physicians in selecting appropriate antibiotics for tuberculosis treatment.

Test Components and Price

  • Test Name: HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test
  • Price: AED 420.0

Sample Condition and Submission

For this test, a sample of 2 mL (minimum 1 mL) of sputum, bronchoalveolar lavage, pleural aspirates, cerebrospinal fluid (CSF), body fluid, or cultured growth on appropriate media should be submitted in a sterile screw capped container. The sample should be placed in a sealed plastic bag and shipped refrigerated. Freezing the sample should be avoided.

Report Delivery

The sample for this test should be submitted on Tuesdays or Fridays by 11 am, and the report will be delivered on Thursdays or Mondays.

Test Method and Type

  • Method: PCR, Line probe assay
  • Test Type: Tuberculosis

Test Department and Doctor

  • Test Department: Molecular Diagnostics
  • Doctor: Physician

Pre Test Information

No special preparation is required before undergoing this test.

Conclusion

The HAINS Mycobacterium Tuberculosis First Line Drug Resistance Profile Test is an essential tool in the diagnosis and treatment of tuberculosis. By identifying drug resistance mutations, this test helps physicians make informed decisions regarding appropriate antibiotics for effective treatment.

Test Name HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE Test
Components
Price 420.0 AED
Sample Condition Submit 2 mL (1 mL min.) Sputum \/ Bronchoalveolar Lavage \/ Pleural aspirates \/ CSF \/ Body fluid OR Cultured growth on appropriate media in a sterile screw capped container in a sealed plastic bag. Ship refrigerated. DO NOT FREEZE
Report Delivery SampleTue / Friby 11 am; Report Thu / Mon
Method PCR, Line probe assay
Test type Tuberculosis
Doctor Physician
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The HAINS Mycobacterium tuberculosis First Line Drug Resistance Profile Test is a molecular diagnostic test used to detect drug resistance mutations in the genes associated with resistance to first-line anti-tuberculosis drugs.

This test specifically targets the genes rpoB, katG, and inhA, which are associated with resistance to rifampicin and isoniazid, two of the most commonly used first-line drugs for tuberculosis treatment.

The HAINS test uses polymerase chain reaction (PCR) technology to amplify and detect specific genetic regions of interest in the Mycobacterium tuberculosis genome. The amplified DNA is then hybridized with specific probes to identify drug resistance mutations.

The results of the test provide information on the presence or absence of drug resistance mutations in the targeted genes, helping to guide the selection of appropriate antibiotics for tuberculosis treatment.